ArsenalBio
Healthcare & Life Sciences
Recent Finacing
Series C
Recent Raise
$325M
Arsenal Biosciences, Inc. is a clinical-stage company developing programmable T cell therapies for solid tumor cancers using a computationally driven approach.
Focus Areas
programmable cell therapy
clinical development
T cell engineering
solid tumor cancers
computational approach
therapeutic candidates
Investors
